Back to search
FDAFDA · Food and drugs·Recall number D-1379-2020

Cetrotide (cetrorelix acetate for Injection) 0.25 mg, Sterile - for subcutaneous use only, Rx Only, Manufactured for: EMD Serono, Inc., Rockland, MD 02370, NDC: 44087-1225-1

Published July 15, 2020 · Recall initiated: June 29, 2020

Summary

FDA records drug Class II recall D-1379-2020, published July 15, 2020 and initiated June 29, 2020. Recalling firm: EMD Serono, Inc.; Status: Terminated; Reported quantity: 30,756 vials; Lot: Lot # 8J025A; 8J025B, Exp 09/30/2020. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Defective Container: Market complaints of missing rubber stoppers from drug vial. Missing rubber stoppers could lead to lack of sterility assurance.

What to do

Voluntary: Firm initiated · Letter

Get an email if CETROTIDE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
CETROTIDE
Manufacturer
EMD Serono, Inc.
Distributor
Nationwide in the US
Lot
Lot # 8J025A; 8J025B, Exp 09/30/2020
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Cetrotide (cetrorelix acetate for Injection) 0.25 mg, Sterile - for subcutaneous use only, Rx Only, Manufactured for: EMD Serono, Inc., Rockland, MD 02370, NDC: 44087-1225-1 recalled?

Yes. FDA published recall D-1379-2020 on July 15, 2020. Reported hazard: Defective Container: Market complaints of missing rubber stoppers from drug vial. Missing rubber stoppers could lead to lack of sterility assurance.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: CETROTIDE.